Related Experiment Video

Updated: Aug 7, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

NOTCH signaling as a novel cancer therapeutic target

L Miele1, H Miao, B J Nickoloff

  • 1Cutaneous Oncology Program, Cardinal Bernardin Cancer Center and Departments of Pathology and Microbiology-Immunology, Loyola University Chicago, Maywood, IL 60153, USA.

Current Cancer Drug Targets
|July 20, 2006
PubMed

Insights

NOTCH signaling regulates cell fate and is implicated in cancer. Gamma-secretase inhibitors targeting NOTCH are explored as novel cancer therapies, despite clinical development challenges.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Oncology

Background:

  • NOTCH-ligand interaction is a conserved mechanism for cell fate decisions during development.
  • NOTCH activation is increasingly linked to the initiation and progression of human cancers.
  • Targeted cancer therapies focus on specific molecular mechanisms, making NOTCH a potential target.

Purpose of the Study:

  • To review the evidence linking NOTCH signaling to various cancers.
  • To explore the therapeutic potential of NOTCH inhibitors in cancer treatment.
  • To identify challenges in the clinical development of NOTCH inhibitors.

Main Methods:

  • Literature review of studies on NOTCH signaling in cancer.
  • Analysis of the role of gamma-secretase in NOTCH activation.
  • Examination of existing and emerging NOTCH signaling inhibitors.

Main Results:

  • NOTCH signaling is implicated in the tumorigenesis of several human cancers.
  • Gamma-secretase inhibitors (GSIs) and other NOTCH inhibitors show promise as anti-cancer agents.
  • Clinical development of these inhibitors faces significant challenges.

Conclusions:

  • NOTCH signaling represents a viable target for novel cancer therapeutics.
  • GSIs and other NOTCH inhibitors offer potential new treatment strategies.
  • Overcoming clinical development hurdles is crucial for realizing the therapeutic benefits of NOTCH inhibition in cancer.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...